Six-month, phase I/II trial of sNN 0029 for amyotrophic lateral sclerosis.
Phase of Trial: Phase I/II
Latest Information Update: 16 Sep 2013
At a glance
- Drugs SNN 0029 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; Therapeutic Use
- 16 Sep 2013 Planned initiation date changed to 1 Dec 2013.
- 06 Feb 2013 New trial record